OPTIMAL FELODIPINE DOSE WHEN COMBINED WITH METOPROLOL IN ARTERIAL-HYPERTENSION - A SWEDISH MULTICENTER STUDY WITHIN PRIMARY HEALTH-CARE

被引:14
作者
BRUN, J
FROBERG, L
KRONMANN, P
OLSSON, LB
SKOOG, P
TYGESEN, G
BENGTSSON, C
SCHERSTEN, B
TIBBLIN, G
机构
[1] UNIV GOTEBORG, DEPT PRIMARY HLTH CARE, REDBERGSVAGEN 6, S-41665 GOTHENBURG, SWEDEN
[2] UNIV UPPSALA, DEPT PRIMARY HLTH CARE, S-75105 UPPSALA, SWEDEN
[3] UNIV LUND, DEPT PRIMARY HLTH CARE, S-22101 LUND, SWEDEN
[4] PRIMARY HLTH CARE CTR, HUDIKSVALL, SWEDEN
[5] PRIMARY HLTH CARE CTR, HOGANAS, SWEDEN
[6] PRIMARY HLTH CARE CTR, SODERHAMN, SWEDEN
[7] PRIMARY HLTH CARE CTR, KRISTINEHAMN, SWEDEN
[8] PRIMARY HLTH CARE CTR, BOLLNAS, SWEDEN
[9] PRIMARY HLTH CARE CTR, LJUNGBY, SWEDEN
关键词
D O I
10.1097/00005344-199015004-00021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S60 / S64
页数:5
相关论文
共 9 条
[1]   FELODIPINE VERSUS HYDROCHLOROTHIAZIDE AS AN ADDITION TO A BETA-BLOCKER IN THE TREATMENT OF HYPERTENSION [J].
BORGMASTARS, H ;
FORSEN, B ;
TUOMILEHTO, J ;
HELLEBO, R ;
WALLE, PO ;
NIELSEN, HM ;
NIELSEN, E ;
WINKEL, O ;
STEINESS, E ;
IBSEN, H .
DRUGS, 1987, 34 :136-138
[2]  
EDGAR B, 1987, CARDIOVASC DRUG THER, V1, P232
[3]   MICROVASCULAR MECHANISMS INVOLVED IN CALCIUM-ANTAGONIST EDEMA FORMATION [J].
GUSTAFSSON, D .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 10 :S121-S131
[4]   ANTIHYPERTENSIVE EFFECT OF FELODIPINE OR HYDRALAZINE WHEN ADDED TO BETA-BLOCKER THERAPY [J].
HANSSON, L ;
DAHLOF, B ;
GUDBRANDSSON, T ;
HELLSING, T ;
KULLMAN, S ;
KUYLENSTIERNA, J ;
LEPPERT, J ;
MOLLER, B ;
SKOGSTROM, K ;
SVENSSON, A ;
SVENSSON, O ;
UGANDER, L .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 12 (01) :94-101
[5]   FELODIPINE VERSUS PRAZOSIN AS AN ADDITION TO A BETA-BLOCKER IN THE TREATMENT OF ESSENTIAL-HYPERTENSION - THE AUSTRALIAN MULTICENTER STUDY [J].
JACKSON, B ;
MORGAN, TO ;
GIBSON, J ;
ANDERSON, A .
DRUGS, 1987, 34 :109-119
[6]  
KJELLSTROM T, 1988, ACTA CLIN BELG S12, V43, pP78
[7]   VASCULAR SELECTIVITY OF FELODIPINE [J].
LJUNG, B .
DRUGS, 1985, 29 :46-58
[8]   THE POTENTIAL FOR ADDED BENEFITS WITH BETA-BLOCKERS AND CALCIUM-ANTAGONISTS IN TREATING CARDIOVASCULAR DISORDERS [J].
NAYLER, WG .
DRUGS, 1988, 35 :1-8
[9]  
NILSSONEHLE P, 1988, J CARDIOVASC PHAR S6, V12, pS183